Mode
Text Size
Log in / Sign up

Fork-tip and Franseen needles provide higher diagnostic accuracy for autoimmune pancreatitis than reverse/forward-bevel needlesSpecific Needle Types Improve Diagnosis of Autoimmune Pancreatitis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that Fork-tip and Franseen needles provide significantly higher diagnostic accuracy than reverse/forward-bevel needles.

This meta-analysis evaluates the diagnostic performance of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) in patients with autoimmune pancreatitis. The analysis included a total sample size of 732 patients to assess accuracy, sample adequacy, and safety across various needle types and sizes.

The study found an overall diagnostic accuracy of 79% (95% CI: 73%-83%) for EUS-FNB. Specifically, Fork-tip needles showed a 90% (95% CI: 80%-99%) accuracy rate, while Franseen needles demonstrated 83% (95% CI: 75%-90%). In contrast, reverse/forward-bevel needles had a significantly lower diagnostic accuracy of 51% (95% CI: 31%-71%). Additionally, 22G needles showed higher accuracy (85%) compared to 19G/20G needles (70%).

The authors note that direct comparative evidence is lacking for specific needle choices. However, the data suggests that Fork-tip and Franseen designs may be preferred options due to statistically significant differences in performance over standard bevel needles. The procedure demonstrated high sample adequacy at 97% and a low adverse event rate of 4%.

How this fits prior evidence

This meta-analysis addresses a gap in diagnostic precision for autoimmune pancreatitis, which can be clinically similar to other pancreatic pathologies. It builds upon prior evidence regarding the importance of accurate diagnosis in IgG4-related disease to avoid overtreatment of pancreatic masses by providing specific data on needle types that improve diagnostic accuracy.

A review of data from 732 patients with autoimmune pancreatitis (AIP) looked at how different needles perform during an endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB). This procedure is used to help doctors confirm a diagnosis when other tests are not clear. The study found that the overall accuracy for this test was about 79%.

Researchers compared different needle designs and sizes. They found that Fork-tip needles had a 90% accuracy rate, while Franseen needles showed 83% accuracy. In contrast, reverse or forward-bevel needles were less accurate at 51%. Additionally, smaller 22G needles performed better than larger 19G or 20G needles. The study also noted that the procedure had a high sample adequacy rate of 97%.

The procedure was generally safe, with an adverse event rate of only 4%. While these findings suggest that specific needle types like Franseen or Fork-tip may be better options for doctors to choose, it is important to note that direct comparative evidence for every specific choice is still limited. Patients should discuss these technical details with their medical team.

What this means for you:
Specific needle types and sizes can improve the accuracy of diagnosing autoimmune pancreatitis during biopsies.

Common questions

How accurate is the biopsy procedure for autoimmune pancreatitis?

The overall diagnostic accuracy of the endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is about 79%. The study found that specific needle types, such as Fork-tip and Franseen needles, showed higher accuracy rates than other designs. These tests are helpful when imaging or blood work results are not clear.

Are there different types of needles used in the procedure?

Yes, several needle types were compared. Fork-tip needles had a 90% accuracy rate and Franseen needles had an 83% accuracy rate. These performed significantly better than reverse or forward-bevel needles, which had a 51% accuracy rate. Additionally, 22G needles showed higher accuracy than 19G or 20G needles.

Is the biopsy procedure safe for patients?

The study reported that the procedure is generally well-tolerated with a low adverse event rate of only 4%. The sample adequacy rate was high at 97%, meaning the procedure is effective at obtaining enough material to help doctors reach a diagnosis.

Study Details

Study typeMeta analysis
Sample sizen = 732
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BACKGROUND AND AIM: Autoimmune pancreatitis (AIP) is a rare chronic form of pancreatitis mediated by autoimmune mechanisms. Evidence regarding the diagnostic performance of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) in AIP remains limited. This study aimed to estimate the pooled diagnostic accuracy of EUS-FNB in patients with AIP. METHODS: PubMed, Embase, Cochrane Library, CNKI, and Wanfang Database were systematically searched to identify fully published studies evaluating EUS-FNB for tissue sampling in AIP. Pooled estimates were generated using a random-effects model. The assessed outcomes included diagnostic accuracy, sample adequacy, contribution to AIP diagnosis, and adverse events. RESULTS: Sixteen studies, including one randomized controlled trial and four prospective studies, comprising 732 patients, were included. The overall diagnostic accuracy was 79% (73%-83%). Diagnostic accuracy was higher for the Franseen needle (83%, 75%-90%) and Fork-tip needle (90%, 80%-99%) compared with the reverse/forward‑bevel (51%, 31%-71%), with a statistically significant difference (P < 0.001). The 22G needle also demonstrated superior diagnostic accuracy (85%, 79%-91%) compared with 19G/20G needles (70%, 42%-98%) (P < 0.001). The pooled sample adequacy rate was 97% (95%-98%). EUS-FNB contributed to the diagnosis in 69% (50%-88%) of cases where diagnosis could not be established using imaging, serology, or involvement of other organs. The overall adverse event rate was 4% (1%-8%). CONCLUSIONS: EUS-FNB demonstrates excellent histological tissue acquisition and moderate diagnostic accuracy in AIP, with a low rate of adverse events. The 22G Franseen or Fork-tip needles may be a reasonable option, though direct comparative evidence is lacking.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.